How a Winding Path Led to a Life-Saving Test | Ep.2: Health Compass Podcast
Purvesh Khatri, a Stanford professor with a background in electronics, software, and computational immunology, unveiled a rapid blood test that detects sepsis within minutes. The assay shortens diagnosis time dramatically, enabling clinicians to start targeted therapy far earlier than traditional methods. Early pilot data show reduced time to antibiotic administration and improved survival rates for critically ill patients. Khatri attributes the breakthrough to interdisciplinary research and advanced data analytics applied to diverse patient populations.
Neurotechnology’s Role Beyond Drugs in Treating Brain Disorders
The video spotlights neurotechnology as a burgeoning alternative to pharmaceuticals for brain‑disorder treatment, emphasizing its capacity to directly modulate neural activity without crossing the blood‑brain barrier. Speakers highlight that synchronized light and sound—so‑called sensory ramps—can activate brain circuits, while brain‑computer interfaces,...
P&S: Architectures & Algorithms for Health & Life Sciences - L1: Course Introduction (Spr 2026)
Welcome to the first lecture of the ETH Zurich “Architectures & Algorithms for Health and Life Sciences” project‑seminar, presented by PhD candidate Nika Mansuriyasi. The session outlines the course’s scope, objectives, and its relevance amid accelerating biotechnological data generation. Mansuriyasi explains...
Sub-Q Bionics Company Showcase | MedTech World Middle East 2026
At MedTech World Middle East 2026, Sub‑Q Bionics CEO Jordan Pollack unveiled a “bionic lymph node,” an implantable microporous device with an integrated pump that continuously drains excess lymphatic fluid. The system syncs to a cloud‑based platform that applies AI...
Malta as a Living Lab for Precision Oncology | MedTech World Middle East 2026
At MedTech World Middle East 2026, Prof. Christian Scerri unveiled a plan to turn Malta into a living lab for precision oncology, leveraging its single national health system, compact ecosystem, and EU‑aligned regulatory framework. He outlined a roadmap that includes...
GCC MedTech Boom: Market, Funding & Scaling | MedTech World Middle East 2026
At MedTech World Middle East 2026, a panel of GCC health leaders highlighted the region’s rapid shift from a pure healthcare consumer to a burgeoning hub for MedTech, biotech, and digital health innovation. National visions and transformation strategies are driving...
The Surprising Impact of Drug Price Negotiation on Clinical Trials
The podcast examines a new Health Affairs paper that tracks how the Inflation Reduction Act’s Medicare drug‑price negotiation provision has affected biopharmaceutical clinical‑trial activity. Dr. So Young Kang and co‑authors compare industry‑sponsored trial initiations from 2015‑2024, focusing on firms directly hit...
The Conjugation Conundrum: The Realities of Conjugated LNP Manufacturing
The discussion centers on the emerging complexities of conjugated lipid nanoparticle (LNP) manufacturing, a shift from standard platform processes toward targeted RNA delivery. Sujit explains that adding a biologic ligand to LNPs forces manufacturers to revisit every process parameter—viscosity, shear...
The “Art” Of the Linker: Complexity, Biodegradability, and Scale in Active LNP R&D
The panel examined the emerging “active” delivery paradigm for lipid nanoparticle (LNP) therapeutics, focusing on the added layers of complexity introduced by ligand‑modified formulations and the need for robust R&D pipelines. Participants contrasted passive LNPs with active, ligand‑decorated versions, highlighting...
The Challenges Novel Lipids Pose For mRNA-LNP Manufacturing
Novel lipid chemistries are accelerating mRNA‑LNP innovation, but they also upend established manufacturing platforms. According to CMC consultant Sujit Jain, each new lipid class forces a fresh round of process development, demanding new impurity profiling strategies and vendor qualification. The...
Novel Lipid Chemistries & Their Impact on Passive LNP Delivery
In a recent Advancing RNA Live session, Dominik Witzigmann of NanoVation and John Zuris of Stealth Co dissected emerging lipid chemistries that enhance passive lipid nanoparticle (LNP) delivery. They highlighted breakthroughs in ionizable lipids, helper lipids, and PEG‑lipids that improve...
How Microfluidics & QbD Are Maturing LNP Manufacturing
In a recent discussion, CMC consultant Sujit Jain and NanoVation CEO Dominik Witzigmann highlighted how microfluidic platforms combined with Quality‑by‑Design (QbD) principles are transforming lipid nanoparticle (LNP) production for mRNA therapeutics. They noted that continuous‑flow microfluidics now enable precise control...
Primates, Patents, & Progress: Advancements In Rational LNP Design
In a recent Advancing RNA Live segment, Dominik Witzigmann of NanoVation Therapeutics and John Zuris of Stealth Co discussed the latest scientific breakthroughs shaping lipid nanoparticle (LNP) design. They highlighted rational, data‑driven approaches that improve particle stability, targeting precision, and...
The Evolving CMC Landscape for mRNA-LNPs
In a recent Advancing RNA Live segment, CMC consultant Sujit Jain outlined the current maturity levels across process development, analytical methods, and supply‑chain logistics for mRNA‑LNP products. He highlighted that COVID‑19 vaccines and liver‑targeted therapeutics now operate on a reproducible,...
Investing in Biotech with Verdad Capital
The Yet Another Value podcast featured Verdad Capital’s Dan Rasmmanson and Greg Obachen discussing their new research paper on quantitative, value‑oriented investing in biotech. The duo explains why biotech, despite representing roughly a quarter of the Russell 2000, is routinely...
FDA Direct: Combating Rare Diseases at the FDA
The FDA Direct town hall marked Rare Disease Day with a candid conversation between FDA leaders Jim and Elizabeth, who both have personal ties to rare‑disease advocacy. Their discussion highlighted the agency’s growing focus on rare‑disease patients, the establishment...
The Hidden Link Between Inflammation and Cholesterol | Behind the Breakthrough
The video explains that atherosclerotic plaque is primarily driven by chronic inflammation rather than merely cholesterol accumulation, highlighting a paradigm shift in heart‑disease research. Researchers at NYU Langone discovered that macrophages ingest cholesterol using receptors meant for bacteria, which stalls the...
NIH SciBites: Pursuing Lab-Grown Organs Through Stem Cell Studies
The video spotlights NIH post‑baccalaureate fellow Jack’s work on engineering lab‑grown organs, focusing on how stem cells must be coaxed through differentiation to become functional heart, lung or other tissues. Jack explains that differentiation hinges on the three‑dimensional arrangement of DNA....
Restore Youthfulness & Vitality to the Aging Brain & Body | Dr. Tony Wyss-Coray
The Huberman Lab podcast features Dr. Tony Wyss‑Coray discussing how factors circulating in young blood can rejuvenate the aging brain and body. Using parabiosis—surgically joining the circulatory systems of young and old mice—his lab demonstrated that young‑derived proteins reactivate neural...
A New Approach to Alzheimer’s? Leucadia Therapeutics | MedTech World Middle East 2026
Leucadia Therapeutics unveiled Arethusta, a minimally invasive glymphatic modulator aimed at restoring cerebrospinal fluid outflow to combat Alzheimer’s disease. The company links impaired drainage at the cribriform plate to early Alzheimer’s pathology and presented pre‑clinical ferret data supporting the approach....
The Art and Science of 3D Bioprinting (4 Minutes)
The four‑minute video demystifies 3D bioprinting, describing how engineers replace plastic filament with living bio‑ink to fabricate tissues and organs layer by layer. It explains the workflow: designers create detailed digital blueprints, custom bio‑ink mixtures supply cells and nutrients, printers deposit...
Ecological Niche BSc 3rd Year | Ecological Niche Explained for Csir Net Life Science
The video lectures on ecological niche, defining it as the functional role of a species within its ecosystem, and distinguishes it from habitat, which is merely the physical location where an organism lives. It explains that a niche comprises habitat plus...
Regulatory Evolution to Expedite Drug Development in Japan: A PMDA Initiatives
The video outlines PMDA’s latest regulatory reforms aimed at accelerating drug development in Japan. Since its 2004 inception, the agency has cut review cycles dramatically, yet a growing “drug loss” problem persists as 35% of drugs approved in the United...
Growing Role of Chinese Pharmaceutical Firms in Global Supply Chains
The video highlights how Chinese biotech firms are reshaping global drug supply chains, with Shanghai’s “Pharma Valley” emerging as a hub. Goldman Sachs data show that 46% of new drug molecules entering human trials in the first half of 2025...
Strategy& Insider Podcast - Episode 43 with Dr. Kahina Lang
Dr. Kahina Lang, head of NextGen Drug Delivery at Merk Group, describes building an agile, startup-style international research unit of 40+ experts across three continents focused on organ- and cell-specific mRNA delivery using nanoparticle carriers. The team aims to direct...
Fear Contagion
The video explains a new study on fear contagion – the rapid spread of fear among animals – and its neurochemical basis. Researchers asked whether oxytocin, a hormone linked to love and empathy in mammals, also governs this phenomenon in...
Rice that Beats the Heat
The video reports the discovery of a heat‑responsive gene, QT12, on rice chromosome 12 that determines how the grain copes with rising nighttime temperatures. Researchers screened more than 500 rice varieties in heat‑prone regions, cross‑breeding the top performers until they...
Knowing How Injection Volumes Impact Delivery Options
The panel discussed how the volume that can be self‑administered determines whether a therapy is delivered via a pre‑filled syringe (PFS), an autoinjector, or an infusion system. Speakers emphasized that the deciding factor is the drug’s pharmacokinetic profile. Antibodies that merely...
Relying On Human Factors Clinical Data For Regulatory Approvals
The discussion centered on the growing regulatory focus on human‑factors engineering in medical‑device submissions, especially within the FDA’s Center for Devices and Radiological Health. Participants noted that the agency’s human‑factors experts have become more visible over the past decade, and...
Confirming Study Approaches For Clinical Bridging
During the Drug Delivery Leader Live event, Chief Editor Tom von Gunden prompted panelist Beate Bittner to discuss patient‑centric considerations as drug and delivery products transition to clinical trials. Bittner emphasized that leveraging established platforms and data from previous studies...
Determining Dosing For IV Or Subcutaneous Delivery
In a Drug Delivery Leader Live session, panelist Beate Bittner discussed early‑stage formulation decisions from a patient dosing perspective, comparing intravenous (IV) and subcutaneous (SC) routes. She highlighted how drug stability, bioavailability, administration frequency, and patient convenience shape the choice...
Phase 2 in Sight as Reinvention Reaps Rewards
Perseron Therapeutics announced a strategic shift from rare‑disease research to cancer immunotherapy, centering on its lead asset HMBBD2. The drug activates the newly identified Vista pathway, a departure from the PD‑1 axis that dominates current checkpoint inhibitors. The company reported that...
Oral GLP-1 Breakthrough - Arecor CEO on Improving Bioavailability for Obesity Treatment
The video centers on Arecor’s effort to develop an oral GLP‑1 formulation that overcomes the chronic low‑bioavailability problem plaguing peptide therapeutics, especially for obesity treatment. The CEO highlights that while more than a hundred peptide candidates are in development for...
Company Turnarounds And AI For Infectious Diseases With Seek Labs' Jared Bauer
Jared Bauer, co‑founder and CEO of Seek Labs, detailed his experience turning around biotech firms and launching an integrated AI‑diagnostic and CRISPR‑therapeutics platform for infectious diseases. He highlighted a proof‑of‑concept study against African Swine Fever that markedly reduced viremia in...
NEJM This Week — February 12, 2026
NEJM This Week (Feb 12 2026) highlights several pivotal studies, including promising phase‑III results for novel IgA nephropathy therapies and updated antithrombotic regimens after coronary stenting. Researchers identified the specific antigen driving rare vaccine‑associated clotting syndromes, while a case report underscored the...
Genflow Biosciences, KEFI Gold and Copper, Valereum, Seeing Machines, Arecor Therapeutics, S&U
Proactive’s weekly roundup highlighted six small‑cap stocks delivering notable milestones, ranging from clinical breakthroughs to financing deals. The segment covered Genflow Biosciences’ promising aged‑dog trial, KEFI Gold & Copper’s $340 million project financing in Ethiopia, Valereum’s partnership with RWA.io, Seeing Machines’...
Lupin Q3 Profit Jumps 37%! Is $1 Billion US Sales Next? | Margin Outlook & GLP-1 Big Bet | ET...
Lupin reported a 37% jump in Q3 profit, reaching ₹1,175.5 crore, and reaffirmed its aim to cross $1 billion in U.S. sales this fiscal year. The company also lifted its full‑year EBITDA margin outlook to 27‑28%, up from the prior 29‑30% nine‑month...
LIVE Replay: Where Science Meets Strategy: Inside Life Sciences Consulting
Life sciences consulting sits at the crossroads of scientific innovation, commercial strategy, and healthcare delivery, as highlighted in a 2026 panel featuring leaders from Guidehouse, Clarkston Consulting, ClearView Healthcare Partners, and Roland Berger. The discussion identified key trends such as...
Tiny Robot Fish Could Swim Through the Body Powered by Ultrasound
The video introduces acoustic robotics, where tiny polymer devices are powered solely by ultrasound‑induced bubble dynamics, eliminating wires, batteries, or magnets and opening the door to fully wireless medical microrobots. A thin polymer sheet is laser‑molded with thousands of sub‑millimetre cavities...
IROS 2025 Keynotes - Medical Robots: Li Zhang
Li Zhang’s IROS 2025 keynote highlighted the rapid evolution of miniature biomedical robots, emphasizing magnetic actuation, bio‑hybrid materials, and modular architectures for safe, targeted therapy. He traced the concept back to Richard Feynman’s swallowable‑surgery vision and described how his team fabricates...
IPO Anniversary BioVersys at SIX
BioVersys commemorated its first anniversary on the SIX Swiss Exchange, reaffirming its mission to combat drug‑resistant bacterial infections. The company highlighted how antibiotic resistance now jeopardizes advances such as oncology therapies, underscoring the urgency of new antibiotics. The listing has amplified...
The RNA Multiverse with Julius Lucks
The Nanoccape episode spotlights Professor Julius Lucks, a chemical‑engineer turned synthetic biologist, who explores RNA’s “multiverse” – its ability to fold, wiggle, and act as a molecular computer. Leveraging nanotechnology principles, Lucks and his team engineered RNA sensors that emit...
What if Plastic Didn’t Last Forever? #TEDTalks
The talk introduces a new class of biodegradable bioplastic created by a startup that harnesses bacteria to eat organic waste. Founded in 2018, the company transforms by‑products such as spent brewery yeast into a polymer that behaves like conventional petroleum‑based...
HEALEY ALS Platform Trial Webinar: January 22, 2026 | Research Access
The webinar hosted by the Healey Center at Mass General introduced the ongoing ALS platform trial, highlighted patient‑navigation resources, and announced the upcoming launch of a new drug regimen (NUZ001) in 2026. Organizers explained how the platform trial uses a shared...
Patient Updates From the 2025 ASH Annual Meeting: Leukemia (Part 3)
At the 2025 ASH meeting presenters highlighted two key leukemia developments: a randomized phase II comparison showed lower‑intensity azacitidine plus venetoclax outperformed intensive 7+3 chemotherapy for event‑free survival and remission depth in a selected AML population, and more patients on...
Payments, Pain, and Pragmatic AI in Clinical Trials - Life Sciences Today Podcast Episode 47
Ledger Run CEO John Chanichi describes his journey from engineering and consulting to building a business platform that streamlines clinical-trial operations, with a particular focus on participant payments, study logistics and data workflows. Ledger Run targets biopharma sponsors and CROs...
Weighing Molecules with Light | The Royal Society
Professor Philip Kukura’s Royal Society lecture explored how modern light‑based methods, especially mass spectrometry, let scientists weigh individual molecules— from tiny explosives to massive therapeutic viruses. He began by tracing the historical need for standardized mass, from barley‑based pounds to...
Intellectual Property Issues Between Vaxgen and the New Social Venture
The video examines the intellectual‑property landscape surrounding a new social‑venture partnership between Vaxgen and its licensing partner Janentech. The core agreement grants a not‑for‑profit foundation royalty‑free rights to develop and distribute a vaccine in low‑income regions, while reserving commercial rights...
Meet 2025 President’s Innovation Challenge Finalist: TerraFlow
TerraFlow, a finalist in the 2025 President’s Innovation Challenge, was introduced by founder Dan Freeman, a Harvard‑Med PhD student whose personal loss of his mother to cancer in December 2023 fuels the company’s urgency to speed life‑saving trials. Freeman explains that...
Aminoglycoside and Its Medical Applications (5 Minutes)
The video provides a concise overview of aminoglycoside antibiotics, detailing their mechanism of action, clinical indications, dosing strategies, toxicity profile, and stewardship considerations for modern practice. Dr. Biotech Whisperer explains that these agents bind the bacterial 16S rRNA, freeze the initiation...